JP2021525518A - 細胞をゲノム編集及び活性化するための方法 - Google Patents
細胞をゲノム編集及び活性化するための方法 Download PDFInfo
- Publication number
- JP2021525518A JP2021525518A JP2020566646A JP2020566646A JP2021525518A JP 2021525518 A JP2021525518 A JP 2021525518A JP 2020566646 A JP2020566646 A JP 2020566646A JP 2020566646 A JP2020566646 A JP 2020566646A JP 2021525518 A JP2021525518 A JP 2021525518A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- car
- population
- editing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 332
- 238000010362 genome editing Methods 0.000 title claims abstract description 80
- 230000020411 cell activation Effects 0.000 title description 3
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims abstract description 250
- 210000001744 T-lymphocyte Anatomy 0.000 claims abstract description 223
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 65
- 201000011510 cancer Diseases 0.000 claims abstract description 47
- 210000004027 cell Anatomy 0.000 claims description 460
- 239000000427 antigen Substances 0.000 claims description 278
- 102000036639 antigens Human genes 0.000 claims description 278
- 108091007433 antigens Proteins 0.000 claims description 273
- 108090000623 proteins and genes Proteins 0.000 claims description 119
- 108091008874 T cell receptors Proteins 0.000 claims description 100
- 102000018697 Membrane Proteins Human genes 0.000 claims description 91
- 108010052285 Membrane Proteins Proteins 0.000 claims description 91
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 88
- 102000004169 proteins and genes Human genes 0.000 claims description 67
- 239000012642 immune effector Substances 0.000 claims description 62
- 229940121354 immunomodulator Drugs 0.000 claims description 62
- 108020005004 Guide RNA Proteins 0.000 claims description 61
- 230000003211 malignant effect Effects 0.000 claims description 60
- 230000004913 activation Effects 0.000 claims description 39
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 36
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims description 36
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 35
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 35
- 108091033409 CRISPR Proteins 0.000 claims description 34
- 239000012634 fragment Substances 0.000 claims description 33
- -1 APRIL Proteins 0.000 claims description 31
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 claims description 31
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 30
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 claims description 29
- 102100029452 T cell receptor alpha chain constant Human genes 0.000 claims description 28
- 230000036210 malignancy Effects 0.000 claims description 28
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 claims description 27
- 229940123611 Genome editing Drugs 0.000 claims description 26
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims description 25
- 230000002463 transducing effect Effects 0.000 claims description 25
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 24
- 102000004127 Cytokines Human genes 0.000 claims description 24
- 108090000695 Cytokines Proteins 0.000 claims description 24
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 24
- 230000002950 deficient Effects 0.000 claims description 21
- 239000012636 effector Substances 0.000 claims description 19
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 17
- 238000010354 CRISPR gene editing Methods 0.000 claims description 17
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 17
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims description 16
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims description 16
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 16
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 16
- 239000013598 vector Substances 0.000 claims description 16
- 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 claims description 15
- 108020004999 messenger RNA Proteins 0.000 claims description 15
- 206010066476 Haematological malignancy Diseases 0.000 claims description 14
- 230000003213 activating effect Effects 0.000 claims description 14
- 210000004180 plasmocyte Anatomy 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 230000002062 proliferating effect Effects 0.000 claims description 12
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 claims description 11
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims description 11
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 11
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 claims description 11
- 108091023040 Transcription factor Proteins 0.000 claims description 11
- 239000011324 bead Substances 0.000 claims description 11
- 238000004520 electroporation Methods 0.000 claims description 11
- 230000008685 targeting Effects 0.000 claims description 11
- 230000001225 therapeutic effect Effects 0.000 claims description 11
- 101001005269 Arabidopsis thaliana Ceramide synthase 1 LOH3 Proteins 0.000 claims description 10
- 101001005312 Arabidopsis thaliana Ceramide synthase LOH1 Proteins 0.000 claims description 10
- 102100027203 B-cell antigen receptor complex-associated protein beta chain Human genes 0.000 claims description 10
- 102100028801 Calsyntenin-1 Human genes 0.000 claims description 10
- 101000914491 Homo sapiens B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 claims description 10
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims description 10
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 claims description 10
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims description 10
- 101000668858 Spinacia oleracea 30S ribosomal protein S1, chloroplastic Proteins 0.000 claims description 10
- 101000898746 Streptomyces clavuligerus Clavaminate synthase 1 Proteins 0.000 claims description 10
- 102100035721 Syndecan-1 Human genes 0.000 claims description 10
- 102000040945 Transcription factor Human genes 0.000 claims description 10
- 101000912622 Homo sapiens C-type lectin domain family 12 member A Proteins 0.000 claims description 9
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims description 9
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 claims description 9
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 9
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 9
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims description 9
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims description 9
- 208000003950 B-cell lymphoma Diseases 0.000 claims description 8
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 7
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 7
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 7
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 7
- 101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 claims description 7
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 7
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 claims description 7
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 7
- 108091058545 Secretory proteins Proteins 0.000 claims description 7
- 102000040739 Secretory proteins Human genes 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 6
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 6
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 6
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 6
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 6
- 238000000684 flow cytometry Methods 0.000 claims description 6
- 210000005033 mesothelial cell Anatomy 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 102100027207 CD27 antigen Human genes 0.000 claims description 5
- 108010021064 CTLA-4 Antigen Proteins 0.000 claims description 5
- 229940045513 CTLA4 antagonist Drugs 0.000 claims description 5
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 5
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 5
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims description 5
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims description 5
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 claims description 5
- 102000037982 Immune checkpoint proteins Human genes 0.000 claims description 5
- 108091008036 Immune checkpoint proteins Proteins 0.000 claims description 5
- 102000017578 LAG3 Human genes 0.000 claims description 5
- 101150030213 Lag3 gene Proteins 0.000 claims description 5
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims description 5
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims description 5
- 101710160107 Outer membrane protein A Proteins 0.000 claims description 5
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 5
- 102100038081 Signal transducer CD24 Human genes 0.000 claims description 5
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 claims description 5
- 102100021631 B-cell lymphoma 6 protein Human genes 0.000 claims description 4
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims description 4
- 101000823089 Equus caballus Alpha-1-antiproteinase 1 Proteins 0.000 claims description 4
- 102100027581 Forkhead box protein P3 Human genes 0.000 claims description 4
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 4
- 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 claims description 4
- 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 claims description 4
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 4
- 101000634835 Homo sapiens M1-specific T cell receptor alpha chain Proteins 0.000 claims description 4
- 101000686034 Homo sapiens Nuclear receptor ROR-gamma Proteins 0.000 claims description 4
- 101000634836 Homo sapiens T cell receptor alpha chain MC.7.G5 Proteins 0.000 claims description 4
- 101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 claims description 4
- 101000962461 Homo sapiens Transcription factor Maf Proteins 0.000 claims description 4
- 101000651211 Homo sapiens Transcription factor PU.1 Proteins 0.000 claims description 4
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 4
- 108700018351 Major Histocompatibility Complex Proteins 0.000 claims description 4
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims description 4
- 102100023421 Nuclear receptor ROR-gamma Human genes 0.000 claims description 4
- 101710163270 Nuclease Proteins 0.000 claims description 4
- 101000613608 Rattus norvegicus Monocyte to macrophage differentiation factor Proteins 0.000 claims description 4
- 102100036840 T-box transcription factor TBX21 Human genes 0.000 claims description 4
- 102100039189 Transcription factor Maf Human genes 0.000 claims description 4
- 102100027654 Transcription factor PU.1 Human genes 0.000 claims description 4
- 108010081355 beta 2-Microglobulin Proteins 0.000 claims description 4
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 claims description 4
- 230000002103 transcriptional effect Effects 0.000 claims description 4
- 101710155833 C-C motif chemokine 8 Proteins 0.000 claims description 3
- 102100032768 Complement receptor type 2 Human genes 0.000 claims description 3
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 claims description 3
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 3
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 claims description 3
- 101150081923 IL4 gene Proteins 0.000 claims description 3
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 claims description 3
- 101710091439 Major capsid protein 1 Proteins 0.000 claims description 3
- 102000003735 Mesothelin Human genes 0.000 claims description 3
- 108090000015 Mesothelin Proteins 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 230000000779 depleting effect Effects 0.000 claims description 3
- AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 claims description 3
- 208000004736 B-Cell Leukemia Diseases 0.000 claims description 2
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 2
- 102100027314 Beta-2-microglobulin Human genes 0.000 claims 2
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 2
- 102100023990 60S ribosomal protein L17 Human genes 0.000 claims 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000010361 transduction Methods 0.000 abstract description 27
- 230000026683 transduction Effects 0.000 abstract description 27
- 238000011282 treatment Methods 0.000 abstract description 16
- 238000009169 immunotherapy Methods 0.000 abstract description 9
- 238000010586 diagram Methods 0.000 abstract description 2
- 230000011664 signaling Effects 0.000 description 49
- 108090000765 processed proteins & peptides Proteins 0.000 description 47
- 102000004196 processed proteins & peptides Human genes 0.000 description 35
- 229920001184 polypeptide Polymers 0.000 description 34
- 108020001756 ligand binding domains Proteins 0.000 description 25
- 230000037430 deletion Effects 0.000 description 23
- 230000006870 function Effects 0.000 description 23
- 238000012217 deletion Methods 0.000 description 22
- 108020001507 fusion proteins Proteins 0.000 description 20
- 102000037865 fusion proteins Human genes 0.000 description 20
- 230000027455 binding Effects 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 108010076504 Protein Sorting Signals Proteins 0.000 description 17
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 16
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 16
- 230000003834 intracellular effect Effects 0.000 description 16
- 230000035755 proliferation Effects 0.000 description 16
- 230000000735 allogeneic effect Effects 0.000 description 15
- 230000009977 dual effect Effects 0.000 description 15
- 208000032839 leukemia Diseases 0.000 description 15
- 206010025323 Lymphomas Diseases 0.000 description 14
- 206010042971 T-cell lymphoma Diseases 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 14
- 230000002147 killing effect Effects 0.000 description 14
- 238000007481 next generation sequencing Methods 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 12
- 108700024394 Exon Proteins 0.000 description 12
- 206010035226 Plasma cell myeloma Diseases 0.000 description 12
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 12
- 239000003446 ligand Substances 0.000 description 12
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 11
- 208000034578 Multiple myelomas Diseases 0.000 description 11
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 208000024908 graft versus host disease Diseases 0.000 description 11
- 208000009329 Graft vs Host Disease Diseases 0.000 description 10
- 208000027190 Peripheral T-cell lymphomas Diseases 0.000 description 9
- 102100040678 Programmed cell death protein 1 Human genes 0.000 description 9
- 208000031672 T-Cell Peripheral Lymphoma Diseases 0.000 description 9
- 230000000139 costimulatory effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 9
- 230000001629 suppression Effects 0.000 description 9
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 8
- 108091027967 Small hairpin RNA Proteins 0.000 description 8
- 241000700605 Viruses Species 0.000 description 8
- 208000020968 mature T-cell and NK-cell non-Hodgkin lymphoma Diseases 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 7
- 108090000172 Interleukin-15 Proteins 0.000 description 7
- 102000003812 Interleukin-15 Human genes 0.000 description 7
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 7
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 230000004068 intracellular signaling Effects 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 238000010606 normalization Methods 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 229940124597 therapeutic agent Drugs 0.000 description 7
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 6
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 6
- 208000023275 Autoimmune disease Diseases 0.000 description 6
- 102000019034 Chemokines Human genes 0.000 description 6
- 108010012236 Chemokines Proteins 0.000 description 6
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 6
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 6
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 6
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 6
- 108010002586 Interleukin-7 Proteins 0.000 description 6
- 108091007960 PI3Ks Proteins 0.000 description 6
- 208000033759 Prolymphocytic T-Cell Leukemia Diseases 0.000 description 6
- 206010042970 T-cell chronic lymphocytic leukaemia Diseases 0.000 description 6
- 208000026651 T-cell prolymphocytic leukemia Diseases 0.000 description 6
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 6
- 102000006601 Thymidine Kinase Human genes 0.000 description 6
- 108020004440 Thymidine kinase Proteins 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 6
- 229960002963 ganciclovir Drugs 0.000 description 6
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 6
- 238000012224 gene deletion Methods 0.000 description 6
- 238000001415 gene therapy Methods 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 201000006845 reticulosarcoma Diseases 0.000 description 6
- 208000029922 reticulum cell sarcoma Diseases 0.000 description 6
- 230000019491 signal transduction Effects 0.000 description 6
- 239000004055 small Interfering RNA Substances 0.000 description 6
- 230000009258 tissue cross reactivity Effects 0.000 description 6
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 5
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 5
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 5
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 5
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 5
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 230000006044 T cell activation Effects 0.000 description 5
- 230000006052 T cell proliferation Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 239000013603 viral vector Substances 0.000 description 5
- 208000016683 Adult T-cell leukemia/lymphoma Diseases 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 241000702421 Dependoparvovirus Species 0.000 description 4
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 4
- 101800001494 Protease 2A Proteins 0.000 description 4
- 101800001066 Protein 2A Proteins 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 201000006966 adult T-cell leukemia Diseases 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000001086 cytosolic effect Effects 0.000 description 4
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 210000004700 fetal blood Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000002865 immune cell Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 201000011649 lymphoblastic lymphoma Diseases 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 230000002688 persistence Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 3
- 102100032937 CD40 ligand Human genes 0.000 description 3
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 3
- 102100026550 Caspase-9 Human genes 0.000 description 3
- 108090000566 Caspase-9 Proteins 0.000 description 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 3
- 101000868215 Homo sapiens CD40 ligand Proteins 0.000 description 3
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 3
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 3
- 102000003814 Interleukin-10 Human genes 0.000 description 3
- 108090000174 Interleukin-10 Proteins 0.000 description 3
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 3
- 241000713666 Lentivirus Species 0.000 description 3
- 102100029193 Low affinity immunoglobulin gamma Fc region receptor III-A Human genes 0.000 description 3
- 208000007452 Plasmacytoma Diseases 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 241000700584 Simplexvirus Species 0.000 description 3
- 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 102000015736 beta 2-Microglobulin Human genes 0.000 description 3
- 238000009172 cell transfer therapy Methods 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 102000003675 cytokine receptors Human genes 0.000 description 3
- 108010057085 cytokine receptors Proteins 0.000 description 3
- 206010052015 cytokine release syndrome Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- FOCAHLGSDWHSAH-UHFFFAOYSA-N difluoromethanethione Chemical compound FC(F)=S FOCAHLGSDWHSAH-UHFFFAOYSA-N 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 229940076144 interleukin-10 Drugs 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 210000003071 memory t lymphocyte Anatomy 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 102000035160 transmembrane proteins Human genes 0.000 description 3
- 108091005703 transmembrane proteins Proteins 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 206010073478 Anaplastic large-cell lymphoma Diseases 0.000 description 2
- 206010002961 Aplasia Diseases 0.000 description 2
- 208000025324 B-cell acute lymphoblastic leukemia Diseases 0.000 description 2
- 102100021942 C-C motif chemokine 28 Human genes 0.000 description 2
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 description 2
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 description 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 2
- 101710188619 C-type lectin domain family 12 member A Proteins 0.000 description 2
- 102100025221 CD70 antigen Human genes 0.000 description 2
- 108091079001 CRISPR RNA Proteins 0.000 description 2
- 102100031256 Cyclic GMP-AMP synthase Human genes 0.000 description 2
- 108030002637 Cyclic GMP-AMP synthases Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102100034221 Growth-regulated alpha protein Human genes 0.000 description 2
- 208000017604 Hodgkin disease Diseases 0.000 description 2
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 description 2
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 description 2
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 2
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 2
- 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 2
- 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 description 2
- 101000662909 Homo sapiens T cell receptor beta constant 1 Proteins 0.000 description 2
- 101000662902 Homo sapiens T cell receptor beta constant 2 Proteins 0.000 description 2
- 101000830598 Homo sapiens Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 description 2
- 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 description 2
- 101710120843 Indoleamine 2,3-dioxygenase 1 Proteins 0.000 description 2
- 102100040062 Indoleamine 2,3-dioxygenase 2 Human genes 0.000 description 2
- 101710120841 Indoleamine 2,3-dioxygenase 2 Proteins 0.000 description 2
- 102100026720 Interferon beta Human genes 0.000 description 2
- 102100033101 Interleukin-17B Human genes 0.000 description 2
- 102100033096 Interleukin-17D Human genes 0.000 description 2
- 102100020873 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 description 2
- 108010018951 Interleukin-8B Receptors Proteins 0.000 description 2
- 102100020880 Kit ligand Human genes 0.000 description 2
- 208000030289 Lymphoproliferative disease Diseases 0.000 description 2
- 102100026894 Lymphotoxin-beta Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 108090000630 Oncostatin M Proteins 0.000 description 2
- 102100036154 Platelet basic protein Human genes 0.000 description 2
- 102100030304 Platelet factor 4 Human genes 0.000 description 2
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 2
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 2
- 102100037272 T cell receptor beta constant 1 Human genes 0.000 description 2
- 102100037298 T cell receptor beta constant 2 Human genes 0.000 description 2
- 102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 description 2
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 2
- 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 description 2
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 2
- 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 2
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000016396 cytokine production Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000005782 double-strand break Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003162 effector t lymphocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 201000009277 hairy cell leukemia Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000000527 lymphocytic effect Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 210000000581 natural killer T-cell Anatomy 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- WMLBMYGMIFJTCS-HUROMRQRSA-N (2r,3s,5r)-2-[(9-phenylxanthen-9-yl)oxymethyl]-5-purin-9-yloxolan-3-ol Chemical compound C([C@H]1O[C@H](C[C@@H]1O)N1C2=NC=NC=C2N=C1)OC1(C2=CC=CC=C2OC2=CC=CC=C21)C1=CC=CC=C1 WMLBMYGMIFJTCS-HUROMRQRSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- SXXLKZCNJHJYFL-UHFFFAOYSA-N 4,5,6,7-tetrahydro-[1,2]oxazolo[4,5-c]pyridin-5-ium-3-olate Chemical compound C1CNCC2=C1ONC2=O SXXLKZCNJHJYFL-UHFFFAOYSA-N 0.000 description 1
- 108010082808 4-1BB Ligand Proteins 0.000 description 1
- 102000002627 4-1BB Ligand Human genes 0.000 description 1
- 102100034111 Activin receptor type-1 Human genes 0.000 description 1
- 102100027647 Activin receptor type-2B Human genes 0.000 description 1
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
- 102100031786 Adiponectin Human genes 0.000 description 1
- 206010001413 Adult T-cell lymphoma/leukaemia Diseases 0.000 description 1
- 102100040026 Agrin Human genes 0.000 description 1
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
- 102100024581 Alpha-taxilin Human genes 0.000 description 1
- 102100022416 Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 Human genes 0.000 description 1
- 102100038778 Amphiregulin Human genes 0.000 description 1
- 102000006306 Antigen Receptors Human genes 0.000 description 1
- 108010083359 Antigen Receptors Proteins 0.000 description 1
- 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
- 102100022718 Atypical chemokine receptor 2 Human genes 0.000 description 1
- 102100022716 Atypical chemokine receptor 3 Human genes 0.000 description 1
- 108010028006 B-Cell Activating Factor Proteins 0.000 description 1
- 102000016605 B-Cell Activating Factor Human genes 0.000 description 1
- 230000003844 B-cell-activation Effects 0.000 description 1
- 102100025142 Beta-microseminoprotein Human genes 0.000 description 1
- 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 1
- 102000004152 Bone morphogenetic protein 1 Human genes 0.000 description 1
- 102100028726 Bone morphogenetic protein 10 Human genes 0.000 description 1
- 102100028727 Bone morphogenetic protein 15 Human genes 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
- 102100022546 Bone morphogenetic protein 8A Human genes 0.000 description 1
- 102100022545 Bone morphogenetic protein 8B Human genes 0.000 description 1
- 102100025422 Bone morphogenetic protein receptor type-2 Human genes 0.000 description 1
- 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 description 1
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 1
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 1
- 102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 1
- 101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 1
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 1
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 1
- 102100025074 C-C chemokine receptor-like 2 Human genes 0.000 description 1
- 102100023702 C-C motif chemokine 13 Human genes 0.000 description 1
- 102100023705 C-C motif chemokine 14 Human genes 0.000 description 1
- 102100023703 C-C motif chemokine 15 Human genes 0.000 description 1
- 102100023700 C-C motif chemokine 16 Human genes 0.000 description 1
- 102100023701 C-C motif chemokine 18 Human genes 0.000 description 1
- 102100036842 C-C motif chemokine 19 Human genes 0.000 description 1
- 102100036848 C-C motif chemokine 20 Human genes 0.000 description 1
- 102100036846 C-C motif chemokine 21 Human genes 0.000 description 1
- 102100036850 C-C motif chemokine 23 Human genes 0.000 description 1
- 102100036849 C-C motif chemokine 24 Human genes 0.000 description 1
- 102100021933 C-C motif chemokine 25 Human genes 0.000 description 1
- 102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
- 102100021936 C-C motif chemokine 27 Human genes 0.000 description 1
- 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
- 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
- 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 description 1
- 102100025618 C-X-C chemokine receptor type 6 Human genes 0.000 description 1
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
- 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 1
- 102100025277 C-X-C motif chemokine 13 Human genes 0.000 description 1
- 102100039396 C-X-C motif chemokine 16 Human genes 0.000 description 1
- 102100039435 C-X-C motif chemokine 17 Human genes 0.000 description 1
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 1
- 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 1
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 1
- 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 1
- 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- WMQLLTKSISGWHQ-UHFFFAOYSA-N C1CC(NC(=O)NC)CCC1CCN1CCN(C=2C(=C(Cl)C=CC=2)Cl)CC1 Chemical compound C1CC(NC(=O)NC)CCC1CCN1CCN(C=2C(=C(Cl)C=CC=2)Cl)CC1 WMQLLTKSISGWHQ-UHFFFAOYSA-N 0.000 description 1
- 108010045374 CD36 Antigens Proteins 0.000 description 1
- 102000053028 CD36 Antigens Human genes 0.000 description 1
- 102100040530 CKLF-like MARVEL transmembrane domain-containing protein 1 Human genes 0.000 description 1
- 102100040531 CKLF-like MARVEL transmembrane domain-containing protein 2 Human genes 0.000 description 1
- 102100040527 CKLF-like MARVEL transmembrane domain-containing protein 3 Human genes 0.000 description 1
- 102100040529 CKLF-like MARVEL transmembrane domain-containing protein 4 Human genes 0.000 description 1
- 102100040525 CKLF-like MARVEL transmembrane domain-containing protein 5 Human genes 0.000 description 1
- 102100040528 CKLF-like MARVEL transmembrane domain-containing protein 6 Human genes 0.000 description 1
- 102100040855 CKLF-like MARVEL transmembrane domain-containing protein 7 Human genes 0.000 description 1
- 102100021824 COP9 signalosome complex subunit 5 Human genes 0.000 description 1
- 108091011896 CSF1 Proteins 0.000 description 1
- 101150018129 CSF2 gene Proteins 0.000 description 1
- 101150069031 CSN2 gene Proteins 0.000 description 1
- 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 1
- 102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 102100025466 Carcinoembryonic antigen-related cell adhesion molecule 3 Human genes 0.000 description 1
- 102100028892 Cardiotrophin-1 Human genes 0.000 description 1
- 102100029391 Cardiotrophin-like cytokine factor 1 Human genes 0.000 description 1
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
- 102100025745 Cerberus Human genes 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 102100033380 Chordin Human genes 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
- 102100031615 Ciliary neurotrophic factor receptor subunit alpha Human genes 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 102100030136 Complement C1q tumor necrosis factor-related protein 4 Human genes 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 101150074775 Csf1 gene Proteins 0.000 description 1
- 102100035298 Cytokine SCM-1 beta Human genes 0.000 description 1
- 102100026234 Cytokine receptor common subunit gamma Human genes 0.000 description 1
- 102100038493 Cytokine receptor-like factor 1 Human genes 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 101100421450 Drosophila melanogaster Shark gene Proteins 0.000 description 1
- 102100040897 Embryonic growth/differentiation factor 1 Human genes 0.000 description 1
- 102100033902 Endothelin-1 Human genes 0.000 description 1
- 208000002460 Enteropathy-Associated T-Cell Lymphoma Diseases 0.000 description 1
- 102100023688 Eotaxin Human genes 0.000 description 1
- 208000016937 Extranodal nasal NK/T cell lymphoma Diseases 0.000 description 1
- 108010087819 Fc receptors Proteins 0.000 description 1
- 102000009109 Fc receptors Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 description 1
- 102100039820 Frizzled-4 Human genes 0.000 description 1
- 229940126656 GS-4224 Drugs 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 102100031132 Glucose-6-phosphate isomerase Human genes 0.000 description 1
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 1
- 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 description 1
- 102100038367 Gremlin-1 Human genes 0.000 description 1
- 102100038353 Gremlin-2 Human genes 0.000 description 1
- 102100040895 Growth/differentiation factor 10 Human genes 0.000 description 1
- 102100040898 Growth/differentiation factor 11 Human genes 0.000 description 1
- 102100040896 Growth/differentiation factor 15 Human genes 0.000 description 1
- 102100040892 Growth/differentiation factor 2 Human genes 0.000 description 1
- 102100035364 Growth/differentiation factor 3 Human genes 0.000 description 1
- 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 1
- 102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
- 102100035363 Growth/differentiation factor 7 Human genes 0.000 description 1
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 1
- 108050006583 Growth/differentiation factor 8 Proteins 0.000 description 1
- 102100035970 Growth/differentiation factor 9 Human genes 0.000 description 1
- 102100035688 Guanylate-binding protein 1 Human genes 0.000 description 1
- 102100025594 Guided entry of tail-anchored proteins factor CAMLG Human genes 0.000 description 1
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 1
- 108700010013 HMGB1 Proteins 0.000 description 1
- 101150021904 HMGB1 gene Proteins 0.000 description 1
- 101150046249 Havcr2 gene Proteins 0.000 description 1
- 101710086591 Hepatocyte growth factor-like protein Proteins 0.000 description 1
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
- 102100022132 High affinity immunoglobulin epsilon receptor subunit gamma Human genes 0.000 description 1
- 108091010847 High affinity immunoglobulin epsilon receptor subunit gamma Proteins 0.000 description 1
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
- 102100037907 High mobility group protein B1 Human genes 0.000 description 1
- 101000799140 Homo sapiens Activin receptor type-1 Proteins 0.000 description 1
- 101000937269 Homo sapiens Activin receptor type-2B Proteins 0.000 description 1
- 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 description 1
- 101000775469 Homo sapiens Adiponectin Proteins 0.000 description 1
- 101000959594 Homo sapiens Agrin Proteins 0.000 description 1
- 101000799972 Homo sapiens Alpha-2-macroglobulin Proteins 0.000 description 1
- 101000760787 Homo sapiens Alpha-taxilin Proteins 0.000 description 1
- 101000755762 Homo sapiens Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 Proteins 0.000 description 1
- 101000809450 Homo sapiens Amphiregulin Proteins 0.000 description 1
- 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
- 101000678892 Homo sapiens Atypical chemokine receptor 2 Proteins 0.000 description 1
- 101000678890 Homo sapiens Atypical chemokine receptor 3 Proteins 0.000 description 1
- 101000695367 Homo sapiens Bone morphogenetic protein 10 Proteins 0.000 description 1
- 101000695360 Homo sapiens Bone morphogenetic protein 15 Proteins 0.000 description 1
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
- 101000762375 Homo sapiens Bone morphogenetic protein 3 Proteins 0.000 description 1
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 1
- 101000899388 Homo sapiens Bone morphogenetic protein 5 Proteins 0.000 description 1
- 101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 1
- 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 description 1
- 101000899364 Homo sapiens Bone morphogenetic protein 8A Proteins 0.000 description 1
- 101000899368 Homo sapiens Bone morphogenetic protein 8B Proteins 0.000 description 1
- 101000934635 Homo sapiens Bone morphogenetic protein receptor type-2 Proteins 0.000 description 1
- 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 1
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 1
- 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 1
- 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 1
- 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 1
- 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 description 1
- 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
- 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 description 1
- 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 1
- 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 description 1
- 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 1
- 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 description 1
- 101000897486 Homo sapiens C-C motif chemokine 25 Proteins 0.000 description 1
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
- 101000897494 Homo sapiens C-C motif chemokine 27 Proteins 0.000 description 1
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 description 1
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 1
- 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 description 1
- 101000947174 Homo sapiens C-X-C chemokine receptor type 1 Proteins 0.000 description 1
- 101000856683 Homo sapiens C-X-C chemokine receptor type 6 Proteins 0.000 description 1
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 1
- 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 1
- 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 description 1
- 101000889133 Homo sapiens C-X-C motif chemokine 16 Proteins 0.000 description 1
- 101000889048 Homo sapiens C-X-C motif chemokine 17 Proteins 0.000 description 1
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 1
- 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 1
- 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 1
- 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 description 1
- 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
- 101000749418 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 1 Proteins 0.000 description 1
- 101000749427 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 2 Proteins 0.000 description 1
- 101000749433 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 3 Proteins 0.000 description 1
- 101000749431 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 4 Proteins 0.000 description 1
- 101000749437 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 5 Proteins 0.000 description 1
- 101000749435 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 6 Proteins 0.000 description 1
- 101000749308 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 7 Proteins 0.000 description 1
- 101000896048 Homo sapiens COP9 signalosome complex subunit 5 Proteins 0.000 description 1
- 101000914337 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 3 Proteins 0.000 description 1
- 101000916283 Homo sapiens Cardiotrophin-1 Proteins 0.000 description 1
- 101000989964 Homo sapiens Cardiotrophin-like cytokine factor 1 Proteins 0.000 description 1
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
- 101000914195 Homo sapiens Cerberus Proteins 0.000 description 1
- 101000888518 Homo sapiens Chemokine-like factor Proteins 0.000 description 1
- 101000943798 Homo sapiens Chordin Proteins 0.000 description 1
- 101000993348 Homo sapiens Ciliary neurotrophic factor receptor subunit alpha Proteins 0.000 description 1
- 101000794263 Homo sapiens Complement C1q tumor necrosis factor-related protein 4 Proteins 0.000 description 1
- 101000804771 Homo sapiens Cytokine SCM-1 beta Proteins 0.000 description 1
- 101001055227 Homo sapiens Cytokine receptor common subunit gamma Proteins 0.000 description 1
- 101000956431 Homo sapiens Cytokine receptor-like factor 1 Proteins 0.000 description 1
- 101000893552 Homo sapiens Embryonic growth/differentiation factor 1 Proteins 0.000 description 1
- 101000925493 Homo sapiens Endothelin-1 Proteins 0.000 description 1
- 101000978392 Homo sapiens Eotaxin Proteins 0.000 description 1
- 101000932480 Homo sapiens Fms-related tyrosine kinase 3 ligand Proteins 0.000 description 1
- 101000885581 Homo sapiens Frizzled-4 Proteins 0.000 description 1
- 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 description 1
- 101000746364 Homo sapiens Granulocyte colony-stimulating factor receptor Proteins 0.000 description 1
- 101001032872 Homo sapiens Gremlin-1 Proteins 0.000 description 1
- 101001032861 Homo sapiens Gremlin-2 Proteins 0.000 description 1
- 101000893563 Homo sapiens Growth/differentiation factor 10 Proteins 0.000 description 1
- 101000893545 Homo sapiens Growth/differentiation factor 11 Proteins 0.000 description 1
- 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 description 1
- 101000893585 Homo sapiens Growth/differentiation factor 2 Proteins 0.000 description 1
- 101001023986 Homo sapiens Growth/differentiation factor 3 Proteins 0.000 description 1
- 101001023988 Homo sapiens Growth/differentiation factor 5 Proteins 0.000 description 1
- 101001023964 Homo sapiens Growth/differentiation factor 6 Proteins 0.000 description 1
- 101001023968 Homo sapiens Growth/differentiation factor 7 Proteins 0.000 description 1
- 101001075110 Homo sapiens Growth/differentiation factor 9 Proteins 0.000 description 1
- 101001001336 Homo sapiens Guanylate-binding protein 1 Proteins 0.000 description 1
- 101000932902 Homo sapiens Guided entry of tail-anchored proteins factor CAMLG Proteins 0.000 description 1
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 1
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
- 101000962526 Homo sapiens Hyaluronidase-2 Proteins 0.000 description 1
- 101001076604 Homo sapiens Inhibin alpha chain Proteins 0.000 description 1
- 101001054725 Homo sapiens Inhibin beta B chain Proteins 0.000 description 1
- 101001054832 Homo sapiens Inhibin beta C chain Proteins 0.000 description 1
- 101001054830 Homo sapiens Inhibin beta E chain Proteins 0.000 description 1
- 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 1
- 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 description 1
- 101001015004 Homo sapiens Integrin beta-3 Proteins 0.000 description 1
- 101001034829 Homo sapiens Interferon alpha-10 Proteins 0.000 description 1
- 101001034828 Homo sapiens Interferon alpha-14 Proteins 0.000 description 1
- 101001034835 Homo sapiens Interferon alpha-16 Proteins 0.000 description 1
- 101000959794 Homo sapiens Interferon alpha-2 Proteins 0.000 description 1
- 101000959704 Homo sapiens Interferon alpha-5 Proteins 0.000 description 1
- 101000959714 Homo sapiens Interferon alpha-6 Proteins 0.000 description 1
- 101000999391 Homo sapiens Interferon alpha-8 Proteins 0.000 description 1
- 101000852870 Homo sapiens Interferon alpha/beta receptor 1 Proteins 0.000 description 1
- 101000852865 Homo sapiens Interferon alpha/beta receptor 2 Proteins 0.000 description 1
- 101001054334 Homo sapiens Interferon beta Proteins 0.000 description 1
- 101001054329 Homo sapiens Interferon epsilon Proteins 0.000 description 1
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
- 101001001420 Homo sapiens Interferon gamma receptor 1 Proteins 0.000 description 1
- 101001044447 Homo sapiens Interferon kappa Proteins 0.000 description 1
- 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 description 1
- 101001002466 Homo sapiens Interferon lambda-3 Proteins 0.000 description 1
- 101000999370 Homo sapiens Interferon omega-1 Proteins 0.000 description 1
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 1
- 101001076386 Homo sapiens Interleukin-1 family member 10 Proteins 0.000 description 1
- 101000994815 Homo sapiens Interleukin-1 receptor accessory protein-like 1 Proteins 0.000 description 1
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
- 101001076418 Homo sapiens Interleukin-1 receptor type 1 Proteins 0.000 description 1
- 101001076422 Homo sapiens Interleukin-1 receptor type 2 Proteins 0.000 description 1
- 101001003142 Homo sapiens Interleukin-12 receptor subunit beta-1 Proteins 0.000 description 1
- 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 description 1
- 101000998181 Homo sapiens Interleukin-17B Proteins 0.000 description 1
- 101000998178 Homo sapiens Interleukin-17C Proteins 0.000 description 1
- 101000998176 Homo sapiens Interleukin-17D Proteins 0.000 description 1
- 101000998151 Homo sapiens Interleukin-17F Proteins 0.000 description 1
- 101001019591 Homo sapiens Interleukin-18-binding protein Proteins 0.000 description 1
- 101001055145 Homo sapiens Interleukin-2 receptor subunit beta Proteins 0.000 description 1
- 101001044893 Homo sapiens Interleukin-20 receptor subunit alpha Proteins 0.000 description 1
- 101001044895 Homo sapiens Interleukin-20 receptor subunit beta Proteins 0.000 description 1
- 101001010626 Homo sapiens Interleukin-22 Proteins 0.000 description 1
- 101001044883 Homo sapiens Interleukin-22 receptor subunit alpha-1 Proteins 0.000 description 1
- 101001044887 Homo sapiens Interleukin-22 receptor subunit alpha-2 Proteins 0.000 description 1
- 101000853000 Homo sapiens Interleukin-26 Proteins 0.000 description 1
- 101000852964 Homo sapiens Interleukin-27 subunit beta Proteins 0.000 description 1
- 101001043821 Homo sapiens Interleukin-31 Proteins 0.000 description 1
- 101001043817 Homo sapiens Interleukin-31 receptor subunit alpha Proteins 0.000 description 1
- 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 description 1
- 101000998132 Homo sapiens Interleukin-34 Proteins 0.000 description 1
- 101000998140 Homo sapiens Interleukin-36 alpha Proteins 0.000 description 1
- 101000998126 Homo sapiens Interleukin-36 beta Proteins 0.000 description 1
- 101000998124 Homo sapiens Interleukin-36 gamma Proteins 0.000 description 1
- 101001040964 Homo sapiens Interleukin-36 receptor antagonist protein Proteins 0.000 description 1
- 101000998122 Homo sapiens Interleukin-37 Proteins 0.000 description 1
- 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 1
- 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 description 1
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
- 101001049204 Homo sapiens Kelch-like protein 20 Proteins 0.000 description 1
- 101000716729 Homo sapiens Kit ligand Proteins 0.000 description 1
- 101001139130 Homo sapiens Krueppel-like factor 5 Proteins 0.000 description 1
- 101001054659 Homo sapiens Latent-transforming growth factor beta-binding protein 1 Proteins 0.000 description 1
- 101001054649 Homo sapiens Latent-transforming growth factor beta-binding protein 2 Proteins 0.000 description 1
- 101001054646 Homo sapiens Latent-transforming growth factor beta-binding protein 3 Proteins 0.000 description 1
- 101000978212 Homo sapiens Latent-transforming growth factor beta-binding protein 4 Proteins 0.000 description 1
- 101000967920 Homo sapiens Left-right determination factor 1 Proteins 0.000 description 1
- 101000967918 Homo sapiens Left-right determination factor 2 Proteins 0.000 description 1
- 101001042362 Homo sapiens Leukemia inhibitory factor receptor Proteins 0.000 description 1
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 description 1
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
- 101000764535 Homo sapiens Lymphotoxin-alpha Proteins 0.000 description 1
- 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 description 1
- 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 1
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
- 101001128132 Homo sapiens NACHT, LRR and PYD domains-containing protein 7 Proteins 0.000 description 1
- 101000602237 Homo sapiens Neuroblastoma suppressor of tumorigenicity 1 Proteins 0.000 description 1
- 101000701614 Homo sapiens Nuclear autoantigen Sp-100 Proteins 0.000 description 1
- 101000586302 Homo sapiens Oncostatin-M-specific receptor subunit beta Proteins 0.000 description 1
- 101000731015 Homo sapiens Peptidoglycan recognition protein 1 Proteins 0.000 description 1
- 101001131990 Homo sapiens Peroxidasin homolog Proteins 0.000 description 1
- 101001126487 Homo sapiens Platelet factor 4 variant Proteins 0.000 description 1
- 101000600766 Homo sapiens Podoplanin Proteins 0.000 description 1
- 101000891848 Homo sapiens Protein FAM3D Proteins 0.000 description 1
- 101001039364 Homo sapiens Protein GPR15L Proteins 0.000 description 1
- 101000804792 Homo sapiens Protein Wnt-5a Proteins 0.000 description 1
- 101000855004 Homo sapiens Protein Wnt-7a Proteins 0.000 description 1
- 101001126414 Homo sapiens Proteolipid protein 2 Proteins 0.000 description 1
- 101000781955 Homo sapiens Proto-oncogene Wnt-1 Proteins 0.000 description 1
- 101000825071 Homo sapiens Sclerostin domain-containing protein 1 Proteins 0.000 description 1
- 101000664418 Homo sapiens Secreted Ly-6/uPAR-related protein 1 Proteins 0.000 description 1
- 101000821449 Homo sapiens Secreted and transmembrane protein 1 Proteins 0.000 description 1
- 101000739160 Homo sapiens Secretoglobin family 3A member 1 Proteins 0.000 description 1
- 101000873676 Homo sapiens Secretogranin-2 Proteins 0.000 description 1
- 101000799194 Homo sapiens Serine/threonine-protein kinase receptor R3 Proteins 0.000 description 1
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
- 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 1
- 101000597193 Homo sapiens Telethonin Proteins 0.000 description 1
- 101000670226 Homo sapiens Threonine synthase-like 2 Proteins 0.000 description 1
- 101000799461 Homo sapiens Thrombopoietin Proteins 0.000 description 1
- 101000659879 Homo sapiens Thrombospondin-1 Proteins 0.000 description 1
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
- 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 101000830565 Homo sapiens Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 description 1
- 101000830603 Homo sapiens Tumor necrosis factor ligand superfamily member 11 Proteins 0.000 description 1
- 101000830600 Homo sapiens Tumor necrosis factor ligand superfamily member 13 Proteins 0.000 description 1
- 101000597779 Homo sapiens Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 1
- 101000638255 Homo sapiens Tumor necrosis factor ligand superfamily member 8 Proteins 0.000 description 1
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
- 101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
- 101000679851 Homo sapiens Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
- 101000772122 Homo sapiens Twisted gastrulation protein homolog 1 Proteins 0.000 description 1
- 101000667330 Homo sapiens V-set and transmembrane domain-containing protein 1 Proteins 0.000 description 1
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 1
- 101000750267 Homo sapiens Vasorin Proteins 0.000 description 1
- 101000855019 Homo sapiens WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1 Proteins 0.000 description 1
- 101000803329 Homo sapiens WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 Proteins 0.000 description 1
- 101000795753 Homo sapiens mRNA decay activator protein ZFP36 Proteins 0.000 description 1
- 102100039285 Hyaluronidase-2 Human genes 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000009438 IgE Receptors Human genes 0.000 description 1
- 108010073816 IgE Receptors Proteins 0.000 description 1
- 108010073807 IgG Receptors Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100025885 Inhibin alpha chain Human genes 0.000 description 1
- 102100027004 Inhibin beta A chain Human genes 0.000 description 1
- 102100027003 Inhibin beta B chain Human genes 0.000 description 1
- 102100026812 Inhibin beta C chain Human genes 0.000 description 1
- 102100026818 Inhibin beta E chain Human genes 0.000 description 1
- 102100032818 Integrin alpha-4 Human genes 0.000 description 1
- 102100022337 Integrin alpha-V Human genes 0.000 description 1
- 102100032999 Integrin beta-3 Human genes 0.000 description 1
- 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 description 1
- 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 1
- 102100039734 Interferon alpha-10 Human genes 0.000 description 1
- 102100039733 Interferon alpha-14 Human genes 0.000 description 1
- 102100039728 Interferon alpha-16 Human genes 0.000 description 1
- 102100040018 Interferon alpha-2 Human genes 0.000 description 1
- 102100039948 Interferon alpha-5 Human genes 0.000 description 1
- 102100040007 Interferon alpha-6 Human genes 0.000 description 1
- 102100036532 Interferon alpha-8 Human genes 0.000 description 1
- 102100036714 Interferon alpha/beta receptor 1 Human genes 0.000 description 1
- 102100036718 Interferon alpha/beta receptor 2 Human genes 0.000 description 1
- 102100026688 Interferon epsilon Human genes 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 102100035678 Interferon gamma receptor 1 Human genes 0.000 description 1
- 102100022469 Interferon kappa Human genes 0.000 description 1
- 102100020990 Interferon lambda-1 Human genes 0.000 description 1
- 102100020992 Interferon lambda-3 Human genes 0.000 description 1
- 102100036479 Interferon omega-1 Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108700003107 Interleukin-1 Receptor-Like 1 Proteins 0.000 description 1
- 102100039065 Interleukin-1 beta Human genes 0.000 description 1
- 102100026015 Interleukin-1 family member 10 Human genes 0.000 description 1
- 102100034413 Interleukin-1 receptor accessory protein-like 1 Human genes 0.000 description 1
- 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 1
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 description 1
- 102100026017 Interleukin-1 receptor type 2 Human genes 0.000 description 1
- 102100036706 Interleukin-1 receptor-like 1 Human genes 0.000 description 1
- 108090000177 Interleukin-11 Proteins 0.000 description 1
- 102000003815 Interleukin-11 Human genes 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 102100020790 Interleukin-12 receptor subunit beta-1 Human genes 0.000 description 1
- 108090000176 Interleukin-13 Proteins 0.000 description 1
- 101800003050 Interleukin-16 Proteins 0.000 description 1
- 102000049772 Interleukin-16 Human genes 0.000 description 1
- 102000013691 Interleukin-17 Human genes 0.000 description 1
- 108050003558 Interleukin-17 Proteins 0.000 description 1
- 102100033461 Interleukin-17A Human genes 0.000 description 1
- 102100033105 Interleukin-17C Human genes 0.000 description 1
- 102100033454 Interleukin-17F Human genes 0.000 description 1
- 108090000171 Interleukin-18 Proteins 0.000 description 1
- 102100035017 Interleukin-18-binding protein Human genes 0.000 description 1
- 102100039879 Interleukin-19 Human genes 0.000 description 1
- 108050009288 Interleukin-19 Proteins 0.000 description 1
- 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
- 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
- 102100022706 Interleukin-20 receptor subunit alpha Human genes 0.000 description 1
- 102100022705 Interleukin-20 receptor subunit beta Human genes 0.000 description 1
- 102100030704 Interleukin-21 Human genes 0.000 description 1
- 102100030703 Interleukin-22 Human genes 0.000 description 1
- 102100022723 Interleukin-22 receptor subunit alpha-1 Human genes 0.000 description 1
- 102100022703 Interleukin-22 receptor subunit alpha-2 Human genes 0.000 description 1
- 102000013264 Interleukin-23 Human genes 0.000 description 1
- 108010065637 Interleukin-23 Proteins 0.000 description 1
- 102100036679 Interleukin-26 Human genes 0.000 description 1
- 108010066979 Interleukin-27 Proteins 0.000 description 1
- 102100036712 Interleukin-27 subunit beta Human genes 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 102100021596 Interleukin-31 Human genes 0.000 description 1
- 102100021594 Interleukin-31 receptor subunit alpha Human genes 0.000 description 1
- 102100033501 Interleukin-32 Human genes 0.000 description 1
- 108010067003 Interleukin-33 Proteins 0.000 description 1
- 102000017761 Interleukin-33 Human genes 0.000 description 1
- 102100033499 Interleukin-34 Human genes 0.000 description 1
- 102100033474 Interleukin-36 alpha Human genes 0.000 description 1
- 102100033498 Interleukin-36 beta Human genes 0.000 description 1
- 102100033503 Interleukin-36 gamma Human genes 0.000 description 1
- 102100021150 Interleukin-36 receptor antagonist protein Human genes 0.000 description 1
- 102100033502 Interleukin-37 Human genes 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
- 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 1
- 102000000704 Interleukin-7 Human genes 0.000 description 1
- 102100026236 Interleukin-8 Human genes 0.000 description 1
- 108010002335 Interleukin-9 Proteins 0.000 description 1
- 102100023681 Kelch-like protein 20 Human genes 0.000 description 1
- 101710177504 Kit ligand Proteins 0.000 description 1
- 102100020680 Krueppel-like factor 5 Human genes 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 208000006404 Large Granular Lymphocytic Leukemia Diseases 0.000 description 1
- 206010023791 Large granular lymphocytosis Diseases 0.000 description 1
- 102100027000 Latent-transforming growth factor beta-binding protein 1 Human genes 0.000 description 1
- 102100027017 Latent-transforming growth factor beta-binding protein 2 Human genes 0.000 description 1
- 102100023757 Latent-transforming growth factor beta-binding protein 4 Human genes 0.000 description 1
- 102100040508 Left-right determination factor 1 Human genes 0.000 description 1
- 102100040511 Left-right determination factor 2 Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
- 102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 1
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 description 1
- 101001089108 Lotus tetragonolobus Anti-H(O) lectin Proteins 0.000 description 1
- 101710099301 Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102100035304 Lymphotactin Human genes 0.000 description 1
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
- 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
- 102100026238 Lymphotoxin-alpha Human genes 0.000 description 1
- 108090000362 Lymphotoxin-beta Proteins 0.000 description 1
- 102000034655 MIF Human genes 0.000 description 1
- 108060004872 MIF Proteins 0.000 description 1
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101001129122 Mannheimia haemolytica Outer membrane lipoprotein 2 Proteins 0.000 description 1
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 description 1
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
- 102100030550 Menin Human genes 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
- 101000597780 Mus musculus Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 1
- 101100268066 Mus musculus Zap70 gene Proteins 0.000 description 1
- 102100031902 NACHT, LRR and PYD domains-containing protein 7 Human genes 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 102100037142 Neuroblastoma suppressor of tumorigenicity 1 Human genes 0.000 description 1
- 101100385413 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) csm-3 gene Proteins 0.000 description 1
- 102100030436 Nuclear autoantigen Sp-100 Human genes 0.000 description 1
- 108010042215 OX40 Ligand Proteins 0.000 description 1
- 102000004473 OX40 Ligand Human genes 0.000 description 1
- 101000642171 Odontomachus monticola U-poneritoxin(01)-Om2a Proteins 0.000 description 1
- 102100031942 Oncostatin-M Human genes 0.000 description 1
- 102100030098 Oncostatin-M-specific receptor subunit beta Human genes 0.000 description 1
- 102100040557 Osteopontin Human genes 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 102100037499 Parkinson disease protein 7 Human genes 0.000 description 1
- 102100032393 Peptidoglycan recognition protein 1 Human genes 0.000 description 1
- 102100034601 Peroxidasin homolog Human genes 0.000 description 1
- 101710201137 Photosystem II manganese-stabilizing polypeptide Proteins 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 102100030582 Platelet factor 4 variant Human genes 0.000 description 1
- 102100037265 Podoplanin Human genes 0.000 description 1
- 208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 108010032428 Protein Deglycase DJ-1 Proteins 0.000 description 1
- 102100040821 Protein FAM3D Human genes 0.000 description 1
- 102100041028 Protein GPR15L Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108091008611 Protein Kinase B Proteins 0.000 description 1
- 102100020729 Protein Wnt-7a Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 102100030486 Proteolipid protein 2 Human genes 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 101710156592 Putative TATA-binding protein pB263R Proteins 0.000 description 1
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 101100047461 Rattus norvegicus Trpm8 gene Proteins 0.000 description 1
- 102000005622 Receptor for Advanced Glycation End Products Human genes 0.000 description 1
- 108010045108 Receptor for Advanced Glycation End Products Proteins 0.000 description 1
- 102100022432 Sclerostin domain-containing protein 1 Human genes 0.000 description 1
- 102100038583 Secreted Ly-6/uPAR-related protein 1 Human genes 0.000 description 1
- 102100021853 Secreted and transmembrane protein 1 Human genes 0.000 description 1
- 102100037268 Secretoglobin family 3A member 1 Human genes 0.000 description 1
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 1
- 102100034136 Serine/threonine-protein kinase receptor R3 Human genes 0.000 description 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 description 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
- 229940046176 T-cell checkpoint inhibitor Drugs 0.000 description 1
- 239000012644 T-cell checkpoint inhibitor Substances 0.000 description 1
- 201000008717 T-cell large granular lymphocyte leukemia Diseases 0.000 description 1
- 208000000389 T-cell leukemia Diseases 0.000 description 1
- 101710089528 T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
- 102100040296 TATA-box-binding protein Human genes 0.000 description 1
- 101710145783 TATA-box-binding protein Proteins 0.000 description 1
- 108700012411 TNFSF10 Proteins 0.000 description 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 1
- 102100035155 Telethonin Human genes 0.000 description 1
- 102100039276 Threonine synthase-like 2 Human genes 0.000 description 1
- 102100034195 Thrombopoietin Human genes 0.000 description 1
- 102100036034 Thrombospondin-1 Human genes 0.000 description 1
- 102100024324 Toll-like receptor 3 Human genes 0.000 description 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
- 102100039390 Toll-like receptor 7 Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000013081 Tumor Necrosis Factor Ligand Superfamily Member 13 Human genes 0.000 description 1
- 108010065323 Tumor Necrosis Factor Ligand Superfamily Member 13 Proteins 0.000 description 1
- 102100024568 Tumor necrosis factor ligand superfamily member 11 Human genes 0.000 description 1
- 101710097155 Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 description 1
- 102100024585 Tumor necrosis factor ligand superfamily member 13 Human genes 0.000 description 1
- 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 1
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
- 102100029320 Twisted gastrulation protein homolog 1 Human genes 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 102100039766 V-set and transmembrane domain-containing protein 1 Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 1
- 102100021161 Vasorin Human genes 0.000 description 1
- 102100020722 WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1 Human genes 0.000 description 1
- 102100036021 WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 Human genes 0.000 description 1
- 101150019524 WNT2 gene Proteins 0.000 description 1
- 102000052547 Wnt-1 Human genes 0.000 description 1
- 102000052556 Wnt-2 Human genes 0.000 description 1
- 108700020986 Wnt-2 Proteins 0.000 description 1
- 102000043366 Wnt-5a Human genes 0.000 description 1
- 101100485099 Xenopus laevis wnt2b-b gene Proteins 0.000 description 1
- 102100035804 Zinc finger protein 823 Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000011467 adoptive cell therapy Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 208000015230 aggressive NK-cell leukemia Diseases 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000009175 antibody therapy Methods 0.000 description 1
- 230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960003852 atezolizumab Drugs 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 229950002916 avelumab Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- KMGARVOVYXNAOF-UHFFFAOYSA-N benzpiperylone Chemical compound C1CN(C)CCC1N1C(=O)C(CC=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 KMGARVOVYXNAOF-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000025084 cell cycle arrest Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 108700010039 chimeric receptor Proteins 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006552 constitutive activation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 101150055601 cops2 gene Proteins 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 210000005220 cytoplasmic tail Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000012350 deep sequencing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 229950009791 durvalumab Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 201000003444 follicular lymphoma Diseases 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000006450 immune cell response Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005918 in vitro anti-tumor Effects 0.000 description 1
- 230000005917 in vivo anti-tumor Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 108010019691 inhibin beta A subunit Proteins 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 108090000681 interleukin 20 Proteins 0.000 description 1
- 108010074108 interleukin-21 Proteins 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229960005386 ipilimumab Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000012035 limiting reagent Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 201000007919 lymphoplasmacytic lymphoma Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000001167 myeloblast Anatomy 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 229960003301 nivolumab Drugs 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 229960002621 pembrolizumab Drugs 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 108010011903 peptide receptors Proteins 0.000 description 1
- 102000014187 peptide receptors Human genes 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 210000004986 primary T-cell Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000005227 renal system Anatomy 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000011301 standard therapy Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003970 toll like receptor agonist Substances 0.000 description 1
- 229940044616 toll-like receptor 7 agonist Drugs 0.000 description 1
- 229940044655 toll-like receptor 9 agonist Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000005909 tumor killing Effects 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4631—Chimeric Antigen Receptors [CAR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464402—Receptors, cell surface antigens or cell surface determinants
- A61K39/464411—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464402—Receptors, cell surface antigens or cell surface determinants
- A61K39/464411—Immunoglobulin superfamily
- A61K39/464412—CD19 or B4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
a.T細胞受容体(TCR)保有免疫エフェクター細胞の集団のゲノムを編集すること、
b.免疫エフェクター細胞集団を活性化させること、及び、
c.ゲノム編集免疫エフェクター細胞の前記集団を増殖させること、
の工程を含む、ゲノム編集免疫エフェクター細胞の集団を作製するための方法を開示する。
a.T細胞受容体(TCR)保有免疫エフェクター細胞の集団のゲノムを編集すること、
b.前記免疫エフェクター細胞集団を活性化させること、
c.前記免疫エフェクター細胞集団に、1種または複数種のタンパク質を認識する少なくとも1種のキメラ抗原受容体(CAR)を形質導入すること、及び、
d.ゲノム編集キメラ抗原受容体保有免疫エフェクター細胞の前記集団を増殖させること、
の工程を含む、前記方法。
a.Cas9−CRISPR、及び抗原(複数可)または細胞表面タンパク質(複数可)をコードする遺伝子(複数可)を標的とするgRNAを用いて、T細胞集団における前記1種または複数種の抗原(複数可)または細胞表面タンパク質(複数可)の発現を欠失または抑制すること、
b.前記T細胞集団を活性化させること、
c.前記T細胞集団に、1種または複数種の抗原または細胞表面タンパク質を認識するキメラ抗原受容体を形質導入すること、ならびに、
d.CAR−T細胞の前記集団を増殖させること、
の工程を含む、前記方法。
a.前記T細胞受容体(TCR)またはそのサブユニットの発現を欠失または抑制し、任意選択的に、Cas9−CRISPR、及び抗原(複数可)または細胞表面タンパク質(複数可)をコードする遺伝子(複数可)を標的とするgRNAを用いて、T細胞集団における前記1種または複数種の抗原(複数可)または細胞表面タンパク質(複数可)の発現を欠失または抑制すること、
b.前記T細胞集団を活性化させること、
c.前記T細胞集団に、1種または複数種の抗原または細胞表面タンパク質を認識するキメラ抗原受容体を形質導入すること、ならびに、
d.TCR欠損CAR−T細胞の前記集団を増殖させること、
の工程を含む、前記方法。
a.Cas9−CRISPR、及び抗原(複数可)または細胞表面タンパク質(複数可)をコードする遺伝子を標的とするgRNAを使用して、健康なヒトドナーに由来するT細胞の集団内のCD7遺伝子及びTRAC遺伝子を編集して、CD7及びTRACを欠失/抑制すること、
b.前記T細胞集団を活性化させること、
c.前記T細胞集団に、CD7を認識するキメラ抗原受容体を形質導入すること、ならびに、
d.UCART7細胞の前記集団を増殖させること、
の工程を含む、前記方法。
a.Cas9−CRISPR、及び抗原(複数可)または細胞表面タンパク質(複数可)をコードする遺伝子を標的とするgRNAを使用して、健康なヒトドナーに由来するT細胞の集団内のCD2遺伝子及びCD3ε遺伝子を編集して、CD2及びCD3εを欠失/抑制すること、
b.前記T細胞集団を活性化させること、
c.前記T細胞集団に、CD及びCD3εを認識するタンデムキメラ抗原受容体を形質導入すること、ならびに、
d.tUCART2/3細胞の前記集団を増殖させること、
の工程を含む、前記方法。
本開示は、キメラ抗原受容体保有免疫エフェクター細胞、例えば、T細胞(CAR−T細胞)など、キメラ抗原受容体保有免疫エフェクター細胞を含む医薬組成物、及び、がん、例えば、血液悪性腫瘍の治療用の免疫療法を行うための方法を提供する。
「キメラ抗原受容体(CAR)」とは、本明細書で使用する場合、及び当該技術分野において一般的に使用する場合、抗原が細胞外ドメインに結合すると、細胞に特殊機能を実行させる細胞内ドメイン(シグナル伝達ドメイン)に結合した、抗原特異的細胞外ドメイン(抗原認識ドメイン)を有する組換え融合タンパク質のことを意味する。キメラ抗原受容体は、MHC非依存性抗原に結合するその能力と、その細胞内ドメインを介して活性化シグナルを変換するその能力の両方により、その他の抗原結合因子とは区別される。
特定の実施形態では、本開示は、抗原または細胞表面タンパク質に特異的に結合する単一のCARを含む遺伝子改変T細胞を提供し、T細胞は、その抗原または細胞表面タンパク質を任意選択的に欠損している(例えば、CD7CARTΔCD7細胞)。非限定的な例では、抗原または細胞表面タンパク質の欠損は、(a)キメラ抗原受容体が、修飾された抗原もしくは細胞表面タンパク質にもはや特異的に結合しないように、T細胞が発現する抗原もしくは細胞表面タンパク質を修飾すること(例えば、キメラ抗原受容体が認識する1種もしくは複数種の抗原のエピトープは、1つもしくは複数のアミノ酸変異(例えば、置換または欠失)によって修飾されていてもよく、または、エピトープは、抗原から欠失されていてもよい)、(b)抗原もしくは細胞表面タンパク質の発現が、T細胞において、少なくとも50%、少なくとも60%、少なくとも70%、少なくとも80%、少なくとも90%、もしくはそれ以上低下するように、T細胞を修飾すること、または(c)抗原もしくは細胞表面タンパク質が発現しないように、T細胞を修飾すること(例えば、抗原または細胞表面タンパク質をコードする遺伝子の欠失または破壊により)、によるものである。上記の実施形態のそれぞれでは、CAR−T細胞は、キメラ抗原受容体が特異的に結合する1種または好ましくは全ての抗原または細胞表面タンパク質を欠損していてもよい。1種または複数種の抗原または細胞表面タンパク質を欠損させるT細胞を遺伝的に修飾するための方法は、当該技術分野において十分周知されており、非限定的な例については本明細書に記載している。以下に記載する実施形態では、CRISPR−Cas9システムを用いて、1種または複数種の抗原を欠損させるT細胞を修飾する。これら実施形態のうちのいずれかは、本明細書で開示する方法を用いて実施してもよい。更なる実施形態では、T細胞は自殺遺伝子を含む。
タンデムCAR−T細胞(tCAR−T)は、2つの異なる細胞表面分子(例えば、抗原/タンパク質)と相互作用可能な2つの異なる細胞外リガンド結合(抗原/タンパク質認識)ドメインを含む単一キメラ抗原ポリペプチドを有するT細胞であり、細胞外リガンド結合ドメインは、1つまたは複数のフレキシブルリンカーによって互いに連結し、1種または複数種の共刺激ドメインを共有しており、第1または第2の細胞外リガンド結合ドメインの結合により、1種または複数種の共刺激ドメイン(複数可)、及びシグナル伝達ドメインにわたり、シグナルが伝達される。
一実施形態では、第1の細胞外リガンド結合抗原認識ドメインは、リンカー(例えば、GGGGS)により連結されたVH1及びVL1と呼ばれる重(VH)鎖可変フラグメント及び軽(VL)鎖可変フラグメント、を含み、細胞表面分子、すなわち、悪性T細胞上に発現した抗原を標的とする、一本鎖抗体フラグメント(scFv)を含む。
特定の実施形態では、本開示は、同一エフェクター細胞内に発現した異なる抗原(複数可)または細胞表面タンパク質(複数可)に対する親和性を有する、2つの異なるキメラ抗原受容体ポリペプチドを有する遺伝子改変T細胞を提供し、それぞれのCAR機能は独立している。CARは、異なる抗原(複数可)または細胞表面タンパク質(複数可)に特異的に結合する単一または複数のポリヌクレオチド配列から発現してもよく、T細胞は、CARが結合する抗原(複数可)または細胞表面タンパク質(複数可)を欠損している(例えば、CD7*CD2−dCARΔCD7ΔCD2細胞)。非限定的な例では、抗原(複数可)または細胞表面タンパク質(複数可)の欠損は、(a)キメラ抗原受容体が、修飾された抗原(複数可)もしくは細胞表面タンパク質(複数可)にもはや特異的に結合しないように、T細胞が発現する抗原もしくは細胞表面タンパク質を修飾すること(例えば、キメラ抗原受容体が認識する1種もしくは複数種の抗原のエピトープは、1つもしくは複数のアミノ酸変異(例えば、置換または欠失)によって修飾されていてもよく、または、エピトープは、抗原から欠失されていてもよい)、(b)抗原(複数可)もしくは細胞表面タンパク質(複数可)の発現が、T細胞において、少なくとも50%、少なくとも60%、少なくとも70%、少なくとも80%、少なくとも90%、もしくはそれ以上低下するように、T細胞を修飾すること、または(c)抗原(複数可)もしくは細胞表面タンパク質(複数可)が発現しないように、T細胞を修飾すること(例えば、抗原または細胞表面タンパク質をコードする遺伝子の欠失または破壊により)、によるものである。上記の実施形態のそれぞれでは、CAR−T細胞は、キメラ抗原受容体が特異的に結合する1種または好ましくは全ての抗原または細胞表面タンパク質を欠損していてもよい。1種または複数種の抗原または細胞表面タンパク質を欠損させるT細胞を遺伝的に修飾するための方法は、当該技術分野において十分周知されており、非限定的な例については本明細書に記載している。以下に記載する実施形態では、CRISPR−Cas9システムを用いて、1種または複数種の抗原(複数可)または細胞表面タンパク質(複数可)を欠損させるT細胞を修飾する。これら実施形態のうちのいずれかは、本明細書で開示する方法を用いて実施してもよい。更なる実施形態では、T細胞は自殺遺伝子を含む。
TCRならびに細胞表面タンパク質及び抗原を遺伝子編集することに加えて、分泌可能なタンパク質、例えば、サイトカインなどの遺伝子を、本明細書で開示する方法を用いて編集してもよい。ケモカイン及び転写因子を編集してから活性化させてもよい。このような編集を行って、例えば、サイトカイン放出症候群(CRS)の発症または維持を抑制または予防してもよい。CRSは、免疫治療薬(またはその他の免疫学的刺激物)に応答した免疫細胞からの、大規模で急速なサイトカインの放出によって引き起こされる。本明細書で開示する方法を用いて、1つまたは複数のサイトカインまたはケモカインの遺伝子の修飾、破壊、または欠失を達成してもよい。
一部の実施形態では、本明細書で開示する及び/または本明細書で開示する方法を用いて作製されるゲノム編集免疫エフェクター細胞は、1種または複数種のキメラ抗原受容体(CAR)を発現し、医薬品として、すなわち、疾患の治療用に使用され得る。多くの実施形態では、細胞はCAR−T細胞である。
本明細書で使用する場合、以下の用語は、示された意味を有する。本明細書の全体にわたり、その他の定義が現れる場合もある。
以下の工程を採用して、本明細書で開示する遺伝子編集CAR−T細胞を得てもよい。当業者は理解するように、おそらく異なる効率をもたらすであろうが、ある特定の工程を、以下に記載する順で連続的に実施してもよく、または、順不同に実施してもよい。
0日目に、解凍用の緩衝液中で細胞を解凍した。その後、細胞を培地に再懸濁し、編集後、2時間静置した。細胞を回収してカウントした。必要な数の細胞を、室温、100×gで10分間、遠心分離にかけた。上清を完全に除去し、細胞をPBS(1ml)中に再懸濁してから微量遠心チューブに移し、室温、100×gで10分間、遠心分離にかけた。上清を完全に除去してから、予め温めた緩衝液P3中に細胞を再懸濁し、カウントを行って、1mLあたり5×107にカウントを調節した。Cas9/gRNAを入れたチューブに100μLの細胞プール容量を加え、軽く混合してから、全てをNucleocuvette(商標)に移し、それを軽く叩いて気泡を除去した。その後、プログラム(ヒトT細胞刺激EO−115)を使用してエレクトロポレーションを開始した。この手順の後、予め温めた培地に活性化した細胞を移してから、2mLのアリコートで12ウェルプレートに分配した。アリコートした試料を24時間静置した。
図3に示すとおり、10ng/mLのIL−15及び10ng/mLのIL−7を含有するTexMacs培地(Miltenyi)中、37℃で、製造業者の取扱説明書に従いTransAct試薬(Miltenyi)を用いて、ナイーブT細胞を活性化させた。図4〜図7に示すとおり、nucleofector 4D(LonzaプログラムEO−115)を使用して、ナイーブT細胞に、100ulのLonza緩衝液P3中の20ugのTRAC gRNA及び15ugのCas9 mRNAをエレクトロポレーションした。エレクトロポレーション後、10ng/mLのIL−15及び10ng/mLのIL−7を含有するTexMacs培地(Miltenyi)中、37℃で、細胞を、0時間(図4)、4時間(図5)、8時間(図6)、または20時間(図7)静置してから、製造業者の取扱説明書に従いTransAct試薬(Miltenyi)を用いて活性化させた。
CARまたは任意の目的のタンパク質を、遺伝子座、例えば、T細胞受容体用の遺伝子に挿入してもよい。MacLeod et al.(“Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene−Edited CAR T Cells,”Molec Therapy 25(4):P949−961,2017)は、遺伝子改変ホーミングエンドヌクレアーゼ及びAAVドナー鋳型を使用して、天然TCRの遺伝子座を標的としてCAR導入遺伝子を直接挿入することによる、同種異系CART細胞の生成について報告している。この方法で作製された抗CD19CART細胞は、内在性の細胞表面TCRを発現せず、in vitroで強力なエフェクター機能を示し、in vivoマウスモデルにおけるCD19+腫瘍の排除を媒介する。得られた遺伝子編集CART細胞は、前臨床モデルにおいて、in vitro及びin vivoで強力な抗腫瘍活性を示し、CD19+血液悪性腫瘍を有する非血縁患者における養子細胞療法としての安全かつ有効な使用の可能性をこれらの細胞が有していることを示唆している。
Washington University Genome Engineering & iPSCにおいて、ガイドRNAを設計して活性を確認した。任意のgRNAに対して相補的な配列は、標的遺伝子座を含むがこれらに限定されないゲノム中にわたり存在し得る。短い配列はオフターゲットにハイブリダイズする可能性がより高い。同様に、gRNA内のある程度長い配列は、ゲノム中にわたり、完全マッチ(長_0)またはニアマッチ(それぞれ、単一のヌクレオチド差または2つのヌクレオチド差を表す、長_1、長_2)を有し得る。これらもまたオフターゲットにハイブリダイズする、要するに、関係ない遺伝子の編集をもたらして編集効率を低下させる場合がある。
Claims (84)
- ゲノム編集免疫エフェクター細胞の集団を作製するための方法であって、
a.T細胞受容体(TCR)保有免疫エフェクター細胞の集団のゲノムを編集すること、
b.前記免疫エフェクター細胞集団を活性化させること、及び、
c.ゲノム編集免疫エフェクター細胞の前記集団を増殖させること、
の工程を含む、前記方法。 - 前記T細胞受容体(TCR)保有免疫エフェクター細胞は、1種または複数種のタンパク質を認識する少なくとも1種のキメラ抗原受容体(CAR)を形質導入されている、請求項1に記載の方法。
- 前記ゲノム編集工程(a)は、前記免疫エフェクター細胞集団に、前記1種または複数種のCARを形質導入することを含む、請求項2に記載の方法。
- 工程(b)と工程(c)の間に実施される、前記免疫エフェクター細胞集団に、前記1種または複数種のCARを形質導入する追加の工程を含む、請求項2に記載の方法。
- a.T細胞受容体(TCR)保有免疫エフェクター細胞の集団のゲノムを編集すること、
b.前記免疫エフェクター細胞集団を活性化させること、
c.前記免疫エフェクター細胞集団に、1種または複数種のタンパク質を認識する少なくとも1種のキメラ抗原受容体(CAR)を形質導入すること、及び、
d.ゲノム編集キメラ抗原受容体保有免疫エフェクター細胞の前記集団を増殖させること、
の工程を含む、ゲノム編集キメラ抗原受容体(CAR)保有免疫エフェクター細胞の集団を作製するための方法である、請求項4に記載の方法。 - 前記免疫エフェクター細胞は精製されている、請求項5に記載の方法。
- 前記免疫エフェクター細胞はT細胞である、請求項6に記載の方法。
- 前記キメラ抗原受容体(CAR)が認識する前記1種または複数種のタンパク質は、抗原及び細胞表面タンパク質から選択される、請求項7に記載の方法。
- ゲノムは、CRISPR関連タンパク質(Cas−CRISPR)、転写活性化因子様エフェクターヌクレアーゼ(TALEN)、またはジンクフィンガーヌクレアーゼ(ZFN)を使用して、編集される、請求項8に記載の方法。
- ゲノムは、Cas−CRISPRを使用して編集される、請求項9に記載の方法。
- 前記ゲノムは、Cas9−CRISPRを使用して編集される、請求項10に記載の方法。
- 前記Cas9は、mRNAまたはタンパク質として前記細胞内に送達される、請求項11に記載の方法。
- 前記Cas9は、mRNAとして前記細胞内に送達される、請求項12に記載の方法。
- 前記Cas9は、タンパク質として前記細胞内に送達される、請求項12に記載の方法。
- 編集される前記遺伝子を標的とするガイドRNA(gRNA)は、前記Cas9と同時に送達される、請求項12に記載の方法。
- 前記送達はエレクトロポレーションによる、請求項15に記載の方法。
- 前記ゲノム編集は、1種または複数種の抗原、細胞表面タンパク質、または分泌可能なタンパク質の発現を欠失または抑制することを含む、請求項16に記載の方法。
- 欠失/抑制される細胞表面タンパク質は、主要組織適合遺伝子複合体I(MHCI)またはそのサブユニットである、請求項17に記載の方法。
- 前記サブユニットはβ2ミクログロブリン(B2M)である、請求項18に記載の方法。
- 欠失/抑制される細胞表面タンパク質は、T細胞受容体(TCR)またはそのサブユニットである、請求項17に記載の方法。
- 欠失/抑制される細胞表面タンパク質は、TRAC(TCR−α)、TCR−β、CD3ε、CD3ζ、CD3δ、及びCD3γ、から選択される、請求項20に記載の方法。
- 欠失/抑制される細胞表面タンパク質はTRACである、請求項21に記載の方法。
- 欠失/抑制される細胞表面タンパク質は、T細胞の消耗を防止するタンパク質である、請求項17に記載の方法。
- T細胞の消耗を防止する細胞表面タンパク質は、T細胞上の免疫チェックポイントである、請求項23に記載の方法。
- T細胞の消耗を防止する前記表面タンパク質は、PD−1、LAG−3、Tim−3、及びCTLA−4、から選択される、請求項24に記載の方法。
- 前記ゲノム編集は、1種または複数種の分泌可能なタンパク質の発現を欠失または抑制することを含む、請求項16に記載の方法。
- 前記分泌可能なタンパク質はサイトカインである、請求項26に記載の方法。
- 前記サイトカインは、MCP1(CCL2)、MCP−2、GM−CSF、G−CSF、M−CSF、Il−4、及びIFNγ、から選択される、請求項27に記載の方法。
- 前記サイトカインはGM−CSFである、請求項28に記載の方法。
- 前記分泌可能なタンパク質は転写因子である、請求項26に記載の方法。
- 前記転写因子は、AHR、BCL6、FOXP3、GATA3、MAF、RORC、SPI1、TBX21、から選択される、請求項30に記載の方法。
- 欠失/抑制される細胞表面タンパク質または抗原は、CAR(複数可)の標的である、請求項17に記載の方法。
- 前記細胞は、編集後最長48時間静置されてから活性化される、請求項1に記載の方法。
- 前記細胞は、編集後最長24時間静置されてから活性化される、請求項1に記載の方法。
- 前記細胞は、編集後最長8時間静置されてから活性化される、請求項1に記載の方法。
- 前記細胞は、編集後最長4時間静置されてから活性化される、請求項1に記載の方法。
- 前記細胞は、編集後24〜48時間静置されてから活性化される、請求項1に記載の方法。
- 前記細胞は、ゲノム編集の直後に活性化される、請求項1に記載の方法。
- 前記免疫エフェクター細胞の前記活性化は、抗CD3抗体及び抗CD28抗体、または上記のいずれかの機能性フラグメントに、前記細胞集団を曝露することによって行われる、請求項37に記載の方法。
- 前記免疫エフェクター細胞の前記活性化は、抗CD3抗体、抗CD28抗体、及び抗CD2抗体、または上記のいずれかの機能性フラグメントに、前記細胞集団を曝露することによって行われる、請求項1に記載の方法。
- 前記抗体はビーズに固定されている、請求項39に記載の方法。
- 前記ゲノム編集細胞は、最長5日間にわたり活性化される、請求項39に記載の方法。
- 前記ゲノム編集細胞は、最長2日間にわたり活性化される、請求項39に記載の方法。
- 前記ゲノム編集細胞は、最長1日間にわたり活性化される、請求項39に記載の方法。
- 前記抗CD3抗体、抗CD28抗体、及び/または抗CD2抗体は、磁場の印加または洗浄により、前記細胞集団から取り除かれる、請求項42のいずれか1項に記載の方法。
- 前記CARは、活性化後48時間未満において、前記細胞に形質導入される、請求項43に記載の方法。
- 前記CARは、活性化後24時間未満において、前記細胞に形質導入される、請求項45に記載の方法。
- 前記CARは、前記CARをコードするレンチウイルスベクターを用いて、前記細胞に形質導入される、請求項46に記載の方法。
- 細胞の前記集団を、20日間未満にわたり増殖させる、請求項48に記載の方法。
- 細胞の前記集団を、12日間未満にわたり増殖させる、請求項48に記載の方法。
- 細胞の前記集団を、10日間未満にわたり増殖させる、請求項48に記載の方法。
- 細胞の前記集団を、8日間未満にわたり増殖させる、請求項48に記載の方法。
- 細胞の前記集団を、6日間未満にわたり増殖させる、請求項48に記載の方法。
- 約25℃〜約40℃の温度で実施される、請求項49に記載の方法。
- 約30℃〜約37℃の温度で実施される、請求項54に記載の方法。
- フローサイトメトリーを用いて前記細胞を解析して、前記CAR(または、複数を形質導入する場合、複数のCAR)の発現を確認する追加の工程を含む、請求項55に記載の方法。
- TCR+細胞を枯渇させる追加の工程を含む、請求項56に記載の方法。
- 使用する前記免疫エフェクター細胞は、健康なドナーから採取される、請求項20に記載の方法。
- 前記ドナーはヒトである、請求項58に記載の方法。
- 前記キメラ抗原受容体(複数可)は、悪性細胞上に発現した少なくとも1種の抗原に特異的に結合する、請求項59に記載の方法。
- 悪性細胞上に発現した前記1種または複数種の抗原は、BCMA、CS1、CD38、CD138、CD19、CD33、CD123、CD371、CD117、CD135、Tim−3、CD5、CD7、CD2、CD4、CD3、CD79A、CD79B、APRIL、CD56、及びCD1a、から選択される、請求項60に記載の方法。
- 前記キメラ抗原受容体(複数可)は、悪性T細胞上に発現した少なくとも1種の抗原に特異的に結合する、請求項60に記載の方法。
- 悪性T細胞上に発現した前記抗原は、CD2、CD3、CD4、CD5、CD7、TCRA、及びTCRβ、から選択される、請求項62に記載の方法。
- 前記キメラ抗原受容体は、悪性形質細胞上に発現した少なくとも1種の抗原に特異的に結合する、請求項60に記載の方法。
- 悪性形質細胞上に発現した前記抗原は、BCMA、CS1、CD38、CD79A、CD79B、CD138、及びCD19、から選択される、請求項64に記載の方法。
- 前記キメラ抗原受容体(複数可)は、悪性B細胞上に発現した少なくとも1種の抗原に特異的に結合する、請求項60に記載の方法。
- 悪性B細胞上に発現した前記抗原は、CD19、CD20、CD21、CD22、CD23、CD24、CD25、CD27、CD38、及びCD45、から選択される、請求項66に記載の方法。
- 悪性B細胞上に発現した前記抗原は、CD19及びCD20から選択される、請求項67に記載の方法。
- 前記キメラ抗原受容体は、悪性中皮細胞上に発現した少なくとも1種の抗原に特異的に結合する、請求項60に記載の方法。
- 悪性中皮細胞上に発現した前記抗原はメソテリンである、請求項69に記載の方法。
- CARがCD7を標的とし、TRAC及びCD7が欠失している、キメラ抗原受容体T(CAR−T)細胞(UCART7細胞)の集団を作製するための方法であって、
a.Cas9−CRISPR、及び抗原(複数可)または細胞表面タンパク質(複数可)をコードする遺伝子を標的とするgRNAを使用して、健康なヒトドナーに由来するT細胞の集団内のCD7遺伝子及びTRAC遺伝子を編集して、CD7及びTRACを欠失/抑制すること、
b.前記T細胞集団を活性化させること、
c.前記T細胞集団に、CD7を認識するキメラ抗原受容体を形質導入すること、ならびに、
d.UCART7細胞の前記集団を増殖させること、
の工程を含む、前記方法。 - CARが、CD2及びCD3εを標的とするタンデムCARであり、CD3ε及びCD2が欠失している、キメラ抗原受容体T(CAR−T)細胞(tUCART2/3細胞)の集団を作製するための方法であって、
a.Cas9−CRISPR、及び抗原(複数可)または細胞表面タンパク質(複数可)をコードする遺伝子を標的とするgRNAを使用して、健康なヒトドナーに由来するT細胞の集団内のCD2遺伝子及びCD3ε遺伝子を編集して、CD2及びCD3εを欠失/抑制すること、
b.前記T細胞集団を活性化させること、
c.前記T細胞集団に、CD2及びCD3εを認識するタンデムキメラ抗原受容体を形質導入すること、ならびに、
d.tUCART2/3細胞の前記集団を増殖させること、
の工程を含む、前記方法。 - 請求項1に記載の方法を用いて作製された、ゲノム編集キメラ抗原受容体保有免疫エフェクター細胞の集団。
- 請求項73に記載のゲノム編集キメラ抗原受容体保有免疫エフェクター細胞の集団、ならびに、少なくとも1種の治療的に許容される担体及び/またはアジュバント、を含む、治療用組成物。
- 請求項1に記載のキメラ抗原受容体保有免疫エフェクター細胞の集団を投与することを含む、患者における固形器官腫瘍を治療するための方法。
- 請求項1に記載のゲノム編集キメラ抗原受容体保有免疫エフェクター細胞の集団を投与することを含む、患者における血液悪性腫瘍を治療するための方法。
- 前記血液悪性腫瘍はT細胞悪性腫瘍である、請求項76に記載の方法。
- 前記T細胞悪性腫瘍はT細胞急性リンパ芽球性白血病(T−ALL)である、請求項77に記載の方法。
- 前記T細胞悪性腫瘍は非ホジキンリンパ腫である、請求項76に記載の方法。
- 前記血液悪性腫瘍はB細胞悪性腫瘍である、請求項76に記載の方法。
- 前記B細胞悪性腫瘍はB細胞リンパ腫である、請求項80に記載の方法。
- 前記B細胞悪性腫瘍はB細胞性白血病である、請求項80に記載の方法。
- 前記血液悪性腫瘍は骨髄性悪性腫瘍である、請求項76に記載の方法。
- 前記骨髄性悪性腫瘍は急性骨髄性白血病である、請求項83に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862678886P | 2018-05-31 | 2018-05-31 | |
US62/678,886 | 2018-05-31 | ||
PCT/US2019/034959 WO2019232409A1 (en) | 2018-05-31 | 2019-05-31 | Methods for genome editing and activation of cells |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021525518A true JP2021525518A (ja) | 2021-09-27 |
JPWO2019232409A5 JPWO2019232409A5 (ja) | 2022-06-08 |
Family
ID=68697155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020566646A Pending JP2021525518A (ja) | 2018-05-31 | 2019-05-31 | 細胞をゲノム編集及び活性化するための方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20200109364A1 (ja) |
EP (1) | EP3801574A4 (ja) |
JP (1) | JP2021525518A (ja) |
CN (1) | CN112867498A (ja) |
WO (1) | WO2019232409A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3802798A4 (en) * | 2018-05-31 | 2022-05-11 | Washington University | CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T) FOR TREATMENT OF CANCER |
WO2021223359A1 (en) * | 2020-05-06 | 2021-11-11 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions and methods for t cell engineering |
CN111849910B (zh) * | 2020-05-27 | 2021-06-15 | 南京北恒生物科技有限公司 | 工程化免疫细胞及其用途 |
US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
CN112980800A (zh) * | 2021-03-08 | 2021-06-18 | 河北森朗生物科技有限公司 | Car-t细胞、其构建方法及其应用 |
CN113430202A (zh) * | 2021-08-26 | 2021-09-24 | 山东兴瑞生物科技有限公司 | 一种具有高敲除率的人PD1基因sgRNA及含有该sgRNA的质粒、T细胞 |
CN113462652A (zh) * | 2021-09-06 | 2021-10-01 | 阿思科力(苏州)生物科技有限公司 | 细胞、免疫治疗产品、基因编辑方法、细胞制备方法及应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017146767A1 (en) * | 2015-02-27 | 2017-08-31 | Icell Gene Therapeutics, Llc | Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof |
WO2017177137A1 (en) * | 2016-04-07 | 2017-10-12 | Bluebird Bio, Inc. | Chimeric antigen receptor t cell compositions |
WO2017193107A2 (en) * | 2016-05-06 | 2017-11-09 | Juno Therapeutics, Inc. | Genetically engineered cells and methods of making the same |
JP2017535261A (ja) * | 2014-10-31 | 2017-11-30 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Cart細胞における遺伝子発現の改変およびその使用 |
WO2018027036A1 (en) * | 2016-08-03 | 2018-02-08 | Dipersio John F | Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors |
JP2018510657A (ja) * | 2015-03-27 | 2018-04-19 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 改変t細胞ならびにそれを作製および使用する方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015066262A1 (en) * | 2013-11-04 | 2015-05-07 | Trustees Of Dartmouth College | Methods for preventing toxicity of adoptive cell therapy |
US10688166B2 (en) * | 2014-11-03 | 2020-06-23 | Cerus Corporation | Compositions and methods for improved car-T cell therapies |
CN108884460B (zh) * | 2016-03-19 | 2023-04-28 | 埃克苏马生物技术公司 | 淋巴细胞转导及其扩增调节的方法与组合物 |
GB201616699D0 (en) * | 2016-09-30 | 2016-11-16 | Mab Designs Ltd | Antibodies |
-
2019
- 2019-05-31 EP EP19812244.2A patent/EP3801574A4/en active Pending
- 2019-05-31 WO PCT/US2019/034959 patent/WO2019232409A1/en unknown
- 2019-05-31 JP JP2020566646A patent/JP2021525518A/ja active Pending
- 2019-05-31 CN CN201980050878.7A patent/CN112867498A/zh active Pending
- 2019-05-31 US US16/428,348 patent/US20200109364A1/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017535261A (ja) * | 2014-10-31 | 2017-11-30 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Cart細胞における遺伝子発現の改変およびその使用 |
WO2017146767A1 (en) * | 2015-02-27 | 2017-08-31 | Icell Gene Therapeutics, Llc | Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof |
JP2018510657A (ja) * | 2015-03-27 | 2018-04-19 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 改変t細胞ならびにそれを作製および使用する方法 |
WO2017177137A1 (en) * | 2016-04-07 | 2017-10-12 | Bluebird Bio, Inc. | Chimeric antigen receptor t cell compositions |
WO2017193107A2 (en) * | 2016-05-06 | 2017-11-09 | Juno Therapeutics, Inc. | Genetically engineered cells and methods of making the same |
WO2018027036A1 (en) * | 2016-08-03 | 2018-02-08 | Dipersio John F | Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors |
Non-Patent Citations (3)
Title |
---|
J. EXP. MED., vol. 215, no. 3, JPN6023025023, 7 February 2018 (2018-02-07), pages 985 - 997, ISSN: 0005086988 * |
LEUKEMIA, vol. 32, no. 9, JPN6023025022, 20 February 2018 (2018-02-20), pages 1970 - 1983, ISSN: 0005086987 * |
SCI. REP., vol. 7, JPN6023025024, 2017, pages 1 - 9, ISSN: 0005086989 * |
Also Published As
Publication number | Publication date |
---|---|
WO2019232409A1 (en) | 2019-12-05 |
CN112867498A (zh) | 2021-05-28 |
US20200109364A1 (en) | 2020-04-09 |
EP3801574A1 (en) | 2021-04-14 |
EP3801574A4 (en) | 2022-03-16 |
WO2019232409A9 (en) | 2020-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7148580B2 (ja) | 特定の組成を有する遺伝子により改変されたt細胞製剤 | |
JP2021525530A (ja) | キメラ抗原受容体細胞治療薬を用いたサイトカイン放出症候群の抑制 | |
JP2021525524A (ja) | がんを治療するためのキメラ抗原受容体t細胞(car−t) | |
JP2021525518A (ja) | 細胞をゲノム編集及び活性化するための方法 | |
JP2022516389A (ja) | 血液悪性腫瘍を治療するためのゲノム編集インバリアントナチュラルキラーT(iNKT)細胞 | |
JP2023038386A (ja) | 細胞免疫療法のための方法および組成物 | |
Allegra et al. | Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells | |
WO2019052577A1 (zh) | 一种基因编辑t细胞及其用途 | |
WO2019154313A1 (zh) | 一种分离的嵌合抗原受体以及包含其的修饰t细胞及用途 | |
US20240158467A1 (en) | Materials and methods for treating cancer | |
JP2024038512A (ja) | がんを治療するための医薬、組み合わせ医薬、医薬組成物、免疫応答性細胞、核酸送達媒体、及び製品 | |
CN112166186A (zh) | 用于t细胞恶性肿瘤的免疫治疗的嵌合抗原受体和cd2的基因编辑 | |
Heiblig et al. | Adoptive immunotherapy for acute leukemia: new insights in chimeric antigen receptors | |
WO2022037562A1 (en) | Engineered immunoresponsive cells and uses thereof | |
WO2022164959A1 (en) | Improved immune cell therapy | |
JP2023516538A (ja) | Ucart細胞を精製する方法及び応用 | |
RU2811466C2 (ru) | Т-клетки с химерными антигенными рецепторами (car-t) для лечения рака | |
US20230190780A1 (en) | Methods for immunotherapy | |
WO2021136176A1 (zh) | 一种靶向t细胞淋巴瘤细胞的通用型car-t及其制备方法和应用 | |
US20230338422A1 (en) | Engineering gamma delta t cells with interleukin-36 for immunotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220531 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220531 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230620 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230915 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231219 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240206 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240502 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20240502 |